Bambi/Akt/Tlr4 axis protects against atherosclerosis by maintaining lipid metabolism homeostasis in macrophages Authors: Xiaochang Chen, Siyu Tan, Siting Li, Peihong Su, Hua Guan, Aoqi Xiang, Lusha Zhang, Haoping Wang, Qi Yu Published: 2025 ABSTRACT AbstractBackground and aimsAtherosclerosis is a chronic inflammatory disease driven by dysregulated lipid metabolism and macrophage dysfunction. However, the role of Bmp and activin membrane-binding inhibitor (Bambi), a pseudoreceptor that antagonizes Tgfβ superfamily signaling, in modulating these processes remains incompletely characterized.MethodsAn adenovirus encoding Bambi (Ad-Bambi) was generated and delivered systemically to Apoe−/− mice. Atherosclerosis was induced by high-fat diet feeding for 14 weeks, after which plaque development and macrophage phenotypes were assessed.ResultsBambi overexpression significantly attenuated the aortic atherosclerotic plaques area, promoted a shift in macrophage polarization from the pro-inflammatory M1 phenotype toward the anti-inflammatory M2 phenotype, and significantly reduced the secretion of key inflammatory cytokines, most notably reducing adhesion G protein-coupled receptor E1 (Adgre1) levels by approximately 40% compared to the control group. In vitro, Bambi overexpression enhanced the lipid metabolic capacity of macrophages, upregulated the cholesterol transporters ATP-binding cassette subfamily A member 1 (Abca1) and ATP-binding cassette subfamily G member 1 (Abcg1), facilitated cholesterol efflux, and suppressed ox-LDL-induced foam cell formation. Transcriptome analysis revealed that Bambi downregulates toll-like receptor 4 (Tlr4) expression via activation of the protein kinase B (Akt) pathway, thereby modulating inflammatory responses and lipid homeostasis in macrophages.ConclusionsThese findings demonstrate that Bambi alleviates macrophage lipid metabolic dysregulation and inhibits foam cell formation through an Akt-dependent signaling mechanism. This suggests that Bambi may exert atheroprotective effect during disease and represents a potential therapeutic target for the prevention or treatment of atherosclerosis.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12944-025-02805-1.Keywords: Bambi, Atherosclerosis, Aorta, RNA sequence, Apoe−/− mice Introduction Atherosclerosis (AS) represents a predominant underlying pathology of cardiovascular diseases and leading cause of global morbidity and mortality [1]. Its pathogenesis is characterized by a multifactorial process involving endothelial dysfunction [2], subendothelial accumulation of lipids (including cholesterol) [3, 4] and prominent inflammatory cell infiltration [5], primarily by macrophages. Furthermore, This is accompanied by the proliferation and migration of vascular smooth muscle cells (VSMCs), which contribute to fibrous cap formation and plaque evolution [6, 7]. The resultant atherosclerotic plaques narrow the vascular lumen, impairing blood flow. Critically, the rupture of unstable plaques can precipitate acute thrombotic events, such as myocardial infarction [8, 9] and stroke [10]. Given its high prevalence and severe clinical sequelae, AS imposes a substantial socioeconomic burden on public health systems worldwide [11, 12]. The formation of macrophage-derived foam cells represents a pivotal event in the pathogenesis of AS plaques [2]. Upon exposure to modified lipoproteins, notably oxidized low-density lipoprotein (ox-LDL), macrophages indiscriminately internalize these lipids via surface scavenger receptors, including Cd36 and oxidized low density lipoprotein receptor 1 (Lox-1), leading to excessive accumulation of esterified cholesterol [13] and the characteristic foamy appearance [14, 15]. These form cells are not merely passive lipid repositories. They actively exacerbate plaque progression by secreting a spectrum of pro-inflammatory cytokines and proteolytic enzymes, thereby sustaining local inflammation and compromising plaque stability [16]. Furthermore, ox-LDL, as a potent bioactive mediator, not only drives foam cell formation but also impairs critical repair functions in vascular endothelial cells (VECs) and VSMCs, thus hindering the resolution of endothelial injury and promoting atherogenesis [17]. The innate immune system, particularly the Toll-like receptor 4 (Tlr4) signaling pathway, is a critical driver of this inflammatory cascade within the atherosclerotic plaque [17, 18]. As a key pattern recognition receptor, Tlr4 recognizes damage-associated molecular patterns, including ox-LDL, initiating a signaling cascade that culminates in the activation of transcription factors like nuclear factor-kappa B (Nf-κb) and the subsequent production of inflammatory mediators [18–20]. The sustained activation of this pathway is a major contributor to the chronic inflammation that characterizes AS. Consequently, endogenous mechanisms that negatively regulate Tlr4 signaling are crucial for maintaining immune homeostasis and preventing excessive inflammation. Conversely, it has been reported that the protein kinase B (Akt) signalling pathway, specifically the PI3K/Akt pathway, exerts negative feedback regulation on the Tlr signalling pathway. Upon activation, the Pi3k/Akt pathway can suppress Tlr4-mediated inflammation through several mechanisms, effectively acting as a brake on the pro-atherogenic inflammatory response and contributing to plaque stabilization. For example, It has been hypothesized that insulin may exert its anti-inflammatory effects by modulating the Pi3k-Akt pathway, thereby contributing to the stabilization of atherosclerotic plaque [21]. Additionally, the Akt pathway promotes the degradation of interleukin-1 receptor-associated kinase (IRAK), further suppressing the Tlr4 signaling cascade [22, 23]. Unlike other negative feedback mechanisms, the PI3K/Akt pathway begins its inhibitory function early in the Tlr4 signaling process. This regulation helps prevent excessive immune activation, maintain internal homeostasis, and prevent the onset of autoimmune diseases. Against this backdrop, Bone Morphogenetic Protein and Activin Membrane-bound Inhibitor (Bambi) has emerged as a molecule of interest with potential relevance to cardiovascular pathology. Bambi is a transmembrane protein that functions as a pseudoreceptor for the transforming growth factor β (Tgfβ) superfamily. Its shares structural homology with type I receptors (Tgfbri/Bmpri) of this family but crucially lacks an intracellular kinase domain, enabling it to act as a dominant-negative inhibitor of Tgfβ and bone morphogenetic protein (Bmp) signaling [24, 25]. Previous studies have implicated Bambi in various biological processes relevant to AS, including the regulation of Tgfβ [25, 26] and Wnt/β-catenin [27] signalling and mitochondrial oxidative stress [24, 28] in adipogenesis process, endothelial cell function in response to ox-LDL [29], and the modulation of macrophage polarization [30, 31]. These findings collectively suggest that Bambi is a pleiotropic regulator that may play a significant role in modulating lipid metabolism and inflammation, two core pillars of atherosclerosis. However, despite these tantalizing connections, the precise role of Bambi within the specific context of macrophage function in atherosclerosis remains poorly understood. While both Bambi and the Akt/Tlr4 signaling axis have been individually implicated in processes fundamental to AS development, a direct functional link between them has not been established. Specifically, whether Bambi exerts its influence on macrophage cholesterol metabolism and inflammatory responses by directly modulating the Akt/Tlr4 signaling axis is a critical unanswered question. Therefore, this study aims to elucidate the intricate regulatory mechanisms by which Bambi modulates Tlr4 signaling in the context of atherosclerosis. The primary objective is to delineate how Bambi influences key pathogenic processes, particularly macrophage foam cell formation, through the Akt signaling pathway. We hypothesize that Bambi acts as a negative regulator of the Tlr4 pathway via Akt-mediated mechanisms, thereby attenuating ox-LDL-induced lipid accumulation and inflammatory responses in macrophages and subsequently impeding Ultimately, this regulatory axis may decelerate the progression of AS. These insights would not only advance the mechanistic understanding of AS but also establish a theoretical basis for considering Bambi as a novel therapeutic target for the prevention and treatment of AS. Materials and methods Animals and diets In this study, male Apoe−/− mice (six weeks old) were obtained from Vital River Company (Vital River Company, Beijing, China) were randomly allocated into two experimental cohorts (n = 10 per group). Animals were housed under a 12-hour light/dark cycle with ad libitum access to food and water. Six-week-old mice were fed with a Clinton-Cybulsky high-fat/high-cholesterol model diet containing 40% fat and 1.25% cholesterol (TP28541, Trophic Animal Feed High-Tech Co.,Ltd, Nantong, China) for 15 weeks. Each mouse received a tail vein injection of either Ad-Bambi or Ad-GFP (control) at a dose of 5 × 108 plaque-forming units every 3 weeks (at weeks 0, 3, 6, 9 and 12). Upon conclusion of the experimental period, euthanasia was performed via intraperitoneal administration of pentobarbital sodium (60–70 mg/kg body weight). All animal procedures were approved by the Laboratory Animal Administration Committee of Xi’an Medical University and conducted in accordance with both the Guidelines for Animal Experimentation of Xi’an Medical University and the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85 − 23, revised 2011). Cell culture RAW264.7 murine monocyte-macrophage leukemia cell line, derived from a male mouse, were procured from Servicebio Technology Co., Ltd. (Cat. STCC20020G). Cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) under standard culture conditions (37 °C, 5% CO₂). To induce foam cell formation, cells were treated with 100 ng/ml ox-LDL in a medium containing 2% FBS for 48 h with the medium being replaced daily to ensure consistent nutrient supply and waste removal. Subsequent lipid accumulation was visualized morphologically using Oil Red O, which specifically targets neutral lipids and cholesteryl esters within cytoplasmic lipid droplets. For quantitative assessment of lipid content, the stained Oil Red O was eluted using isopropanol and the absorbance was measured spectrophotometrically at a wavelength of510 nm. Construction of the adenoviral Bambi vector and infection of HEK293 cells Using a previously published method [13], a recombinant adenoviral vector encoding Bambi (Ad-Bambi) was constructed. The adenoviral shuttle plasmid pAdTrack-CMV was used to subclone the Bambi cDNA. After confirming the sequence, the recombinant shuttle plasmid was transformed into BJ5183 competent cells. HEK293 cells were then used to package and amplify the recombinant adenovirus. TCID50 was used to detect the viral titer. An empty adenoviral vector (Ad-GFP) was constructed as a control. Biochemical analyses After a 12-hour fast period, blood samples were collected from the tail vein of each mouse. The blood was immediately anticoagulated with ethylenediaminetetraacetic acid (EDTA) and centrifuged at 1500 rpm for 10 min at 4℃ to isolate plasma. Plasma concentrations of high-density lipoprotein cholesterol (HDL-C; Cat. BC5325), triglyceride (TG; Cat. BC0625), total cholesterol (TC; Cat. BC1985) and free cholesterol (FC; BC1895) were quantified using commercial assay kits (Solarbio Science & Technology Co., Ltd., Beijing, China), while plasma total glucose concentration was determined with the Glu Kit (Cat. 100000240, Biosino Bio-Technology & Science Inc., Beijing, China). In addition, the cholesterol ester (CE) content was subsequently obtained by subtracting the FC content from the TC content. All measurements were performed in triplicate for each animal, following the manufacturers’ protocols, using a multimode microplate reader (SPARK, TECAN, Austria). Cholesteryl esters hydrolysis measurement To quantify the initial CE mass, a standardized assay was performed following established methodology [32]. Briefly, a subset of cholesterol-loaded RAW264.7 macrophages was processed immediately after the equilibration phase using the method described above. The remaining wells were incubated for 24 h in RPMI 1640 medium supplemented with 5 µg/mL of an acyl-CoA: cholesterol acyltransferase inhibitor (ACATi). By inhibiting the re-esterification of FC derived from CE hydrolysis, the net reduction in cellular CE content over the 24-hour chase period directly reflected the rate of esterified cholesterol clearance. The CE hydrolysis rate was calculated as the percentage of initial CE hydrolyzed during the chase period. Cholesterol efflux assay To quantify cholesterol efflux, a standardized assay was performed following established methodology [33]. Briefly, RAW264.7 macrophages were loaded with a mixture of oxidized low-density lipoprotein (ox-LDL; 100 µg/mL) and [³H]-cholesterol (5 µCi/mL) for 24 h to label the intracellular cholesterol pool. Following three washes with phosphate-buffered saline (PBS), cells were equilibrated in serum-free medium for 2 h at 37 °C to allow for isotopic equilibrium. Cholesterol efflux was subsequently initiated by replacing the serum-free medium with RPMI 1640 medium containing either 20 µg/mL apolipoprotein A-I (apoA-I; Sigma-Aldrich, U.S.A.) or 50 µg/mL HDL (Yiyuan Biotechnology, Guangzhou, China) and incubating for 12 h at 37 °C. After the incubation, the medium was collected and centrifuged to remove cellular debris. The radioactivity (disintegrations per minute, dpm) in the medium and in the cell lysate was measured separately by liquid scintillation counting. Cholesterol efflux capacity was calculated as the percentage of radioactivity released into the medium relative to the total radioactivity (medium + cell lysate): % Efflux = (dpmmedium/dpmmedium+lysate) × 100. Quantification of atherosclerotic lesions Atherosclerosis was quantified by euthanizing mice via an intraperitoneal injection of tribromoethanol (15 mg/kg) and opening their aortic trees, which were subsequently stained with Oil red O. The size of the aortic plaques was analyzed using Image J, an image analysis system. Additionally, frozen sections were cut at the level of the aortic root to examine atherosclerotic lesions microscopically. The analysis entailed the examination of ten cross-sections from each mouse, which were subsequently stained with Oil red O and hematoxylin-eosin (H&E) and quantified using Image J to determine the lesion area. RNA-seq analysis Total RNA was extracted from control and Bambi-overexpressing aortic or RAW 264.7 macrophage cell. The RNA was subjected to transcriptome sequencing by Novogene Company (Beijing, China) using the Illumina sequencing technology. A strand-specific mRNA sequencing library was prepared using the KAPA RNA Adapters set1/set2 for Illumina, following the manufacturer’s instructions. Clustering was performed using the KAPA Stranded RNA-Seq Library Prep Kit (Illumina) with the index-coded samples. After cluster generation, the libraries were subjected to sequencing on the Illumina HiSeq X Ten platform using a paired-end module with a read length of 150 bp. Differentially expressed genes were identified using a P value threshold of 0.05 and a fold-change cutoff of 1.5 between the two groups. Real-Time quantitative polymerase chain reaction (RT-qPCR) analysis Total RNA was extracted from tissue or cell samples using the RNAiso Plus reagent (Cat. 9109, Takara Bio Inc., Beijing, China). An amount of 500 ng RNA was reverse transcribed into cDNA using the PrimeScript™ RT Master Mix (Perfect Real Time) reagent (Cat. RR036A, Takara Bio Inc., Beijing, China). Polymerase chain reaction (PCR) amplification was conducted using the ChamQ SYBR qPCR Master Mix (Cat. Q311-02, Vazyme, Nanjing, China). The primers used in the assay are listed in Table S1. Statistical analysis All the replicate experiments (including cell and mouse-based experiments) are biological replicates that were repeated at least three times. Animals were randomly assigned to experimental groups using a computer-generated random number sequence. Similarly, cell culture plates or samples were processed in a randomized order to avoid systematic bias. All analyses involved the use of SPSS v23 (SPSS Inc., Chicago, IL). Data are presented as scatter plots showing individual values per animal, with the horizontal line indicating the mean and error bars representing SEM. Comparison of two groups was determined by Student’s t-test and multiple groups by one-way ANOVA with Tukey’s post hoc test. The assumption of normality was tested by the Shapiro − Wilks test. All statistical tests were two-tailed, and p < 0.05 was considered statistically significant. Results Overexpression of Bambi in Apoe−/− mice To evaluate the functional consequences of exogenous Bambi overexpression on atherosclerotic lesions, we generated a Bambi-overexpressing adenovirus (Ad-Bambi). Transduction efficiency was first validated in HEK293A cells, where robust green fluorescent protein (GFP) expression, co-expressed from the viral vector, was observed 48 h post-transfection, confirming a transduction efficiency exceeded 90% (Fig. 1A). Subsequently, 8-week-old Apoe−/− mice (n = 10 per group) received a single systemic administration via tail-vein injection of either Ad-Bambi or from the control vector (Ad-GFP). Six days post-injection, quantitative analysis of aortic tissue revealed a significant upregulation of both Bambi mRNA and protein levels in the Ad-Bambi-treated group compared to the Ad-GFP control group (Fig. 1B-D). These data confirm successful establishment of Bambi-overexpressing mouse model, providing a validated system for subsequent investigation of Bambi’s atheroprotective mechanisms. Adenovirus-mediated overexpression of Bambi in Apoe−/− mice. A Representative fluorescence image of adenovirus-infected HEK293A cells, showing efficient transduction. Scale bar: 100 μm. B Quantitative RT-qPCR analysis of Bambi expression in aortic tissues of Apoe⁻/⁻ mice treated with Ad-GFP (control) or Ad-Bambi (n = 4, biological replicates, power = 0.9998931). C, D Western blot analysis and densitometric quantification of Bambi protein levels in aorta isolated from each experimental group, using β-Actin as a loading control (n = 3, biological replicates, power = 0.9996087). All data are presented as Mean ± SEM. Statistical Significance was determined by unpaired two-tailed Student’s t-test analysis (** p < 0.01) Overexpression of Bambi downregulated LDL-C in Apoe−/− mice After confirmation of successful Ad-Bambi transduction, all Apoe−/− mice were maintained on a Clinton-Cybulsky high-fat/high-cholesterol model diet (40% fat, 1.25% cholesterol) for 14 weeks to promote atherogenesis. Physiological and metabolic parameters were systematically evaluated to assess the impact of Bambi overexpression. Analysis revealed no significant difference between the Ad-Bambi and Ad-GFP control groups in cumulative body weight and food intake throughout the study period (Fig. 2A-B). Post-mortem examination further indicated that Bambi overexpression Bambi overexpression did not significantly alter the body weight, liver tissue weight, inguinal white adipose tissue (iWAT) weight, visceral white adipose tissue (eWAT) weight, and brown adipose tissue (BAT) weight (Fig. 2C-G). Biochemical analysis of plasma lipid profiles showed comparable levels of TC, TG, HDL-C, and LDL-C between the two groups (Fig. 2H-J). However, a significant reduction in LDL-C was observed in the Ad-Bambi-treated mice compared to the Ad-GFP controls (Fig. 2K). The above results demonstrate that Bambi overexpression selectively lowers plasma LDL-C levels in a hyperlipidemic mouse model, without exerting broad effects on overall growth, energy balance, or the mass of major lipid-handling tissues, highlighting its potential role in modulating specific pathways of cholesterol homeostasis. Overexpression of Bambi downregulated LDL-C levels in Apoe−/− mice. A, B Body weight and average food intake in Apoe−/− mice administered Ad-GFP or Ad-Bambi and maintained on HFD diet for 15 weeks(Fig. 2B: n = 4, technical replicates). C Representative images and quantitative comparison of body morphology and final body weight after 15 weeks of HFD feeding (n = 10, biological replicates). D-G Morphological appearance and wet weight of the iWAT, eWAT, BAT and liver collected post-sacrifice (n = 10, biological replicates). H-K Fasting serum lipid profiles quantifying TG, TC, HDL, and LDL (n = 10, biological replicates, power2H = 0.9859852, power2K = 0.9613369). All data are presented as Mean ± SEM. Statistical significance was determined by unpaired two-tailed Student’s t-test analysis (**p < 0.01) Increased Production of Bambi diminished the formation of atherosclerosis To evaluate the impact of Bambi overexpression on the development of atherosclerotic plaque, we quantified lesion burden in Apoe−/− mice using two complementary approaches. Firstly, the En face analysis of the entire aortic tree following Oil Red O staining revealed that the Ad-Bambi group exhibited significant reduction in the total atherosclerotic lesion area compared to control group (p < 0.01; Fig. 3A). This macroscopic assessment was corroborated by histological examination of the aortic root. Cross-sectional analysis confirmed that lesion area within the aortic root was reduced by approximately 30–40% in the Ad-Bambi group (p < 0.05; Fig. 3B-C). Furthermore, Oil Red O staining these sections demonstrated a significant reduction of approximately 30% in the lipid-rich core area of the plaques (p < 0.05; Fig. 3B and D). Together, these data from both en face and cross-sectional evaluations indicate that Bambi overexpression effectively attenuates the progression of atherosclerosis by reducing overall plaque burden and lipid accumulation. Increased Production of Bambi diminished the Formation of Atherosclerosis. A Representative en face image of the entire aortic tree stained with Oil Red O (ORO) Oil red O (ORO) to visualize atherosclerotic lesions. B, C Quantitative analysis of the total aortic lesion area B and the percentage of plaque area relative to the total aortic surface area C in each experimental group ( n= 10, biological replicates, power= 0.9217463, power= 0.9073887). D Histological sections of the aortic root stained with ORO (top) to detect lipid accumulation and hematoxylin eosin (H&E; bottom) for morphological assessment. Scale bar: 100 μm. E, F Quantitative analysis of the ORO-positive lipid area E and the cross-sectional lesion area in the aortic root F ( n= 10, biological replicates, power= 0.9623268, power= 0.9440785). All data are presented as Mean ± SEM. Statistical significance was determined by unpaired two-tailed Student’s t-test analysis (* p< 0.05, ** p< 0.01) Overexpression of Bambi promotes macrophages polarization toward the M2 phenotype in aorta tissues To further elucidate the molecular mechanisms underlying the atheroprotective effects of Bambi, we performed high-throughput transcriptome sequencing on aortic samples tissue from Apoe⁻/⁻ mice treated with either Ad-GFP control or Ad-Bambi. Biological in quadruplicate were analyzed using the DESeq2 algorithm with stringent criteria (Benjamini-Hochberg adjustedp ≤ 0.05 and |log2(fold change)|≥1) to identify differentially expressed genes (DEGs). This analysis revealed 983 significant DEGs in Bambi-overexpressing mice compared to controls (Fig. 4A), comprising 557 upregulated and 426 downregulated genes (Fig. 4B). Notably, among the 15 most significantly altered genes were several regulators of macrophage polarization, including hydroxycarboxylic acid receptor 2 (Hcar2), arachidonate 15-lipoxygenase (Alox15), matrix metallopeptidase 9 (Mmp9), arachidonate 12-lipoxygenase (Alox12), and stabilin 2 (Stab2). Overexpression of Bambi promotes macrophages polarization toward the M2 phenotype in aorta tissues. A Heatmap depicting global transcriptomic profiles in aortic tissues from Apoe⁻/⁻ mice administered Ad-GFP or Ad-Bambi and maintained on a HFD for 15 weeks (n = 4, biological replicates). B Volcano plot identifying DEGs between the Ad-Bambi and Ad-GFP group (fold change > 2, adjusted p < 0.05). C, D Validation of selected DEGs by RT-qPCR. Genes expression levels normalized to β-Actin and analyzed using the comparative threshold cycle (ΔΔCT) method. E The top 20 enriched KEGG pathways among DEGs. The rich factor represents the ratio of DEGs annotated in a pathway to all genes associated with that pathway. F Representative immunohistochemistry staining of Mac-2 (a macrophage marker) staining in aortic sections. Scale bar: 100 μm. G Quantification of Mac-2+ area per section (n = 10, biological replicates, power = 0.9130646). H, I The RT-qPCR analysis of key inflammatory and polarization-related genes (Il-1β, Tnfα, iNos for M1; Arg1, Ym1, Il-10 for M2), with β-Actin as an endogenous control (n = 5, biological replicates, power(Adgr1) = 0.9796392, power(Cd68) = 0.9502993, power(Igtax) = 0.9696528, power(Arg1) = 0.9624589, power(Ym1) = 0.9626373). J IF staining of iNOS (M1 marker) and CD206 (M2 marker) in aortic root sections, with DAPI nuclear counterstain. Scale bar: 200 μm. All data are presented as Mean ± SEM. Statistical significance was determined by unpaired two-tailed Student’s t-test analysis (*p < 0.05, **p < 0.01) The reliability of the transcriptomic data was validated through RT-qPCR confirmation of 10 selected DEGs, which showed strong concordance with the RNA-seq results (Fig. 4C-D). KEGG pathway enrichment analysis of the DEGs identified approximately 30 significantly altered pathways involved in macrophage function and inflammation (Fig. 4E), including Cholesterol metabolism, Jak-Stat signaling pathway, Nf-κb signaling pathway, and Pi3k-Akt signaling pathway. In order to provide the direct evidence of Bambi expression in plaque macrophages, we have performed immunofluorescence (IF) staining experiments on aortic from our atherosclerosis mouse model to specifically visualize Bambi expression in plaque macrophages. Strong positive signal for Bambi (green fluorescence) is observed within the atherosclerotic plaques. Co-localization analysis confirms that Bambi expression is predominantly located in cells that are positive for Adgre1 (macrophage marker, red fluorescence), as indicated by yellow signals in the merged images (Fig. S1). This provides direct visual evidence that Bambi is indeed expressed by macrophages residing within the lesions, robustly supporting our previous conclusions drawn from mRNA and protein expression data. Further investigation demonstrated that Bambi overexpression significantly reduced macrophage infiltration, as evidenced by decreased staining area of Mac2+ in aortic sections i (p < 0.05; Fig. 4F). Consistent with this finding, expression of pro-inflammatory factors adhesion G protein-coupled receptor E1 (Adgre1) and Cd68 was substantially suppressed (p < 0.01; Fig. 4H). Given the established relationship between inflammation and macrophage polarization, we assessed polarization states and found that Bambi promoted a shift from pro-inflammatory M1 toward anti-inflammatory M2 phenotype, as confirmed by both RT-qPCR and IF analyses (p < 0.05; Fig. 4I-J). Overexpression of Bambi improves the lipid metabolism environment in macrophages To further validate the aortic findings, we employed the RAW264.7 murine macrophage cell line. Foam cell formation was induced with 100 ng/mL ox-LDL, and cells were transfected with a pcDNA 3.1+-Bambi overexpression plasmid (Bambi pcDNA) using Lipofectamine 3000 to investigate the effects of Bambi in macrophages lipid metabolism. Transfection efficiency analysis confirmed that Bambi pcDNA significantly increased Bambi mRNA levels approximately threefold (Fig. 5A). Oil Red O staining revealed, of Bambi overexpression markedly attenuated ox-LDL-induced macrophage foam cell formation (p < 0.05; Fig. 5B-D). Overexpression of Bambi modulates lipid metabolism in macrophages. A Bambi mRNA expression levels in RAW264.7 macrophages transfected with Bambi NC (negative control) or Bambi pcDNA, as determined by RT-qPCR (n = 5, biological replicates, power = 0.9996156). B-D Representative image and quantitative analysis of Oil Red O-stained lipid droplets in RAW264.7 macrophages treated with 100 ng/mL ox-LDL for 48 h (n = 4, biological replicates, power(2D) = 0.8384630). Scale bar: 100 μm. E-G Intracellular concentrations of concentration of TC, FC, and CE in macrophages (n = 3, biological replicates, power(TC) = 0.8914533, power(FC) = 0.9638826, power(CE) = 0.8932935). H Cholesterol efflux capacity assessed by measuring the release of radiolabeled cholesterol to apoA-I or HDL (n = 5, biological replicates, power = 0.8059804). I mRNA expression levels of cholesterol efflux-related genes (Abca1, Abcg1) normalized to β-Actin (n = 5, biological replicates, power(Abcg1) = 0.8104686). J mRNA expression of cholesterol esterification-related genes (Acat1, Nceh) normalized to β-Actin (n = 5, biological replicates, power(Nceh) = 0.8389741). K Cholesteryl ester hydrolysis rates measured by enzymatic assay (n = 5, biological replicates, power = 0.9167399). L mRNA expression of scavenger receptor-related genes (Cd36, Scara1, Scarb1) normalized to β-Actin (n = 5, biological replicates, power(Cd36) = 0.8511240, power(Scara1) = 0.9392186, power(Scarb1) = 0.8485114). All data are presented as Mean ± SEM. Statistical significance was determined by unpaired two-tailed Student’s t-test analysis (**p < 0.01) Given that cholesterol accumulation drives foam cell formation, we quantified lipid components. Bambi overexpression significantly reduced the TC, FC, and CE content compared to the negative control group (p < 0.05; Fig. 5E-G). This reduction was accompanied by enhanced cholesterol efflux capacity in Bambi-overexpressing macrophages (p < 0.05; Fig. 5H), indicating that Bambi ameliorates lipid metabolism imbalance under atherogenic conditions by reducing the cholesterol deposition. Cholesterol homeostasis is not only on uptake but also on efflux efficiency. Bambi overexpression significantly upregulated mRNA expression of the key efflux transporters ATP-binding cassette subfamily A member 1 (Abca1) and ATP-binding cassette subfamily G member 1 (Abcg1), which mediate cholesterol transfer to apolipoproteins and high-density lipoprotein, respectively (p < 0.05; Fig. 5I). This suggests Bambi enhances cholesterol clearance via the Abca1/Abcg1-dependent pathway. Following lipids uptake, esterification by acyl-CoA: cholesterol acyltransferase (Acat) and hydrolysis by neutral cholesterol ester hydrolase (Nceh) regulate intracellular cholesterol storage. While Bambi overexpression had no significantly affect Acat1 expression, it elevated Nceh mRNA levels (p < 0.05; Fig. 5J) and increased the rate of CE hydrolysis (p < 0.05; Fig. 5K), indicating promoted hydrolysis of cholesteryl esters. Scavenger receptors mediate unregulated uptake of modified lipoproteins like ox-LDL. Bambi overexpression significantly downregulated expression of scavenger receptors scavenger receptor class A, member 1 (Scara1) and scavenger receptor class B, member 1 (Scarb1) (p < 0.05; Fig. 5L), suggesting it modulates lipid metabolism partly by suppressing ox-LDL uptake. Collectively, these results demonstrate that Bambi overexpression attenuates foam cell formation through coordinated regulation of cholesterol efflux, ester hydrolysis, and scavenger receptor expression. Bambi attenuates Tlr4 expression via Akt signaling pathway activation in macrophages To further elucidate the molecular mechanisms by which Bambi modulates the lipid metabolism environment in macrophages, high-throughput transcriptome sequencing was performed on the RAW264.7 macrophage cell line following treatment with either Bambi NC or Bambi pcDNA. Transcriptomic analysis identified 2609 unique DEGs (Fig. 6A), with 1551 upregulated and 1058 downregulated in the Bambi pcDNA group compared to controls (Fig. 6B). Among the 15 most significantly altered genes were several key regulators of macrophage foam cell formation, including fatty acid binding protein 4 (Fabp4), CCAAT/enhancer binding protein α (C/ebpα), Tlr4, Abca1, and Abcg1, suggesting that overexpression of Bambi may attenuate atherosclerotic plaque development by reprogramming lipid handling in macrophages. Bambi attenuates Tlr4 expression via Akt signaling pathway activation in macrophages. A Heatmap depicting global transcriptomic profiles in RAW264.7 macrophages treated with Bambi NC or Bambi pcDNA after the treatment of 100 ng/mL ox-LDL for 48 h (n = 3, biological replicates). B Volcano plot identifying DEGs in the Bambi pcDNA group relative to the Bambi NC control (fold change > 2, adjusted p < 0.05). C, D Validation of selected DEGs by RT-qPCR. Gene expression levels were normalized to β-Actin as and analyzed using the comparative threshold cycle (ΔΔCT) method (n = 3, biological replicates). E The top 20 enriched KEGG pathways among DEGs. The rich factor represents the ratio of DEGs annotated in a pathway all genes associated with that pathway. F, G Western blot analysis of Oxyblot, Bambi, Abca1, Abcg1, p-Akt, Akt and Tlr4 in RAW264.7 macrophages transfected with Bambi pcDNA F or Bambi siRNA G. Protein levels were normalized to β-Actin (n = 3, biological replicates, power(6 F−Bambi) = 0.8691628, power(6 F−Abca1) = 0.8739136, power(6 F−Abcg1) = 0.8626463, power(6 F−p−Akt/Akt) = 0.9935019, power(6 F−Tlr4) = 0.8247605, power(6G−Bambi) = 0.8411949, power(6G−Abca1) = 0.8453782, power(6G−p−Akt/Akt) = 0.8358584, power(6G−Tlr4) = 0.8989377). All data are presented as the Mean ± SEM. Statistical significance was determined by unpaired two-tailed Student’s t-test analysis (*p < 0.05, **p < 0.01) The reliability of the sequencing data was confirmed via RT‑qPCR validation of 10 selected DEGs, which showed strong concordance with the transcriptomic results (Fig. 6C-D). KEGG pathway enrichment analysis revealed significant alterations in approximately 22 pathways, with particular relevance to macrophage function observed in the Toll-like receptor signaling pathway, Drug metabolism-cytochrome P450, and Efferocytosis (Fig. 6E). Of these, Toll-like receptor signaling pathway was further investigated macrophage immune activation and lipid metabolism. Tlr family members, especially Tlr4, are patterns recognition receptors expressed on macrophage surfaces and endosomal membranes that initiate inflammatory responses upon binding pathogen-associated or endogenous ligands. Tlr4 activation not only promotes the release of pro-inflammatory cytokines in macrophages but also modulates genes involved in lipid uptake and metabolism. Furthermore, prior evidence indicates that the Akt signaling pathway can regulate the expression level of Tlr4 through phosphorylation, thereby fine-tuning the intensity of TLR4-mediated immune responses. To determine whether Bambi influences Tlr4 expression via Akt, we transfected RAW264.7 macrophages with pcDNA 3.1 + overexpression plasmids and siRNA. Western Blot analysis demonstrated that Bambi overexpression significantly enhanced Akt phosphorylation and suppressed the Tlr4 protein levels (p < 0.05; Fig. 6F). Conversely, Bambi knockdown reduced Akt phosphorylation and increased Tlr4 expression (p < 0.05; Fig. 6G), indicating that Bambi negatively regulates Tlr4 in an Akt-dependent manner Since mitochondrial oxidative stress and reactive oxygen species (ROS) promote lipid accumulation and foam cell formation, we also assessed the effects of Bambi on mitochondrial oxidative stress. The results showed that Bambi overexpression suppressed markers of mitochondrial oxidative stress, whereas Bambi silencing exacerbates them (Fig. 6F-G), consistent with its role in maintaining lipid homeostasis. Collectively, these results demonstrate that Bambi modulates macrophage lipid metabolism and foam cell formation by activating the Akt pathway, downregulating TLR4, and attenuating mitochondrial oxidative stress, thereby slowing the progression of atherosclerosis. Discussion AS is a chronic inflammatory disease that constitutes the primary pathological basis for major cardiovascular events such as coronary heart disease and stroke. Its pathogenesis involves dysregulated lipid metabolism, endothelial dysfunction, immune-inflammatory activation, and functional impairment of multiple cell types, particularly macrophages. Bambi, initially identified as a pseudoreceptor that inhibits Tgfβ superfamily signaling pathway, has recently garnered attention for its roles in cancer, fibrosis, and inflammation. However, its specific functions and regulatory mechanisms in atherosclerosis, particularly concerning macrophage behavior, remain incompletely elucidated. This study aimed to comprehensively evaluate the impact of Bambi on atherosclerotic progression using an Apoe−/− mouse model that fed a high-fat diet and subjected to adenovirus-mediated Bambi overexpression. Parallel in vitro experiments were conducted to investigate the effects of Bambi on macrophage inflammation, polarization, lipid metabolism, and key signaling pathways such as the Akt/Tlr4 axis. We hypothesized that Bambi overexpression would attenuate atherosclerosis by multi-dimensionally modulating macrophage function. One key finding of this study was that systemic Bambi overexpression significantly reduced high-fat diet-induced atherosclerotic lesions in Apoe−/− mice compared to Ad-GFP control, supporting a protective role for Bambi in the atherosclerosis progression, consistent with its previous reported benefits in other inflammatory [34, 35] and injury models [36]. Firstly, we found that Bambi overexpression significantly increased the protein levels of both Abca1 and Abcg1, which are key transporters in the cholesterol efflux pathway. This finding provides a plausible mechanistic explanation for the observed promotion of cholesterol efflux. Abca1 mediates the initial transfer of cellular phospholipids and cholesterol to lipid-poor apoA-I to form nascent HDL particles, while Abcg1 primarily facilitates further cholesterol efflux to mature HDL. The coordinated upregulation of these transporters by Bambi suggests a synergistic enhancement of the overall cholesterol export capacity from cells. This effect strengthens the RCT pathway, which is fundamental to the anti-atherogenic process of removing excess cholesterol from peripheral tissues, including arterial macrophages, for eventual excretion by the liver. Subsequent in vivo and in vitro analyses, the latter using ox-LDL-stimulated RAW264.7 macrophage, demonstrated that Bambi modulates core aspects of macrophage pathophysiology: it suppressed excessive macrophage inflammatory responses, promoted M2 polarization, and reduced abnormal intracellular lipid accumulation, thereby inhibiting foam cell formation and improving the plaque microenvironment, suggesting its potential as a therapeutic target for ameliorating atherosclerosis. Mechanistically, high-throughput RNA sequencing analysis of Bambi-overexpressing macrophages revealed significant alterations in the Toll-like receptor signaling pathway, notably involving Tlr4, a key receptor for both pathogen, and damage-associated molecular patterns, including ox-LDL components. Our comprehensive results strongly suggest that Bambi appears to regulate macrophage function through a novel Akt–Tlr4 axis: the activation of the Akt leads to Tlr4 downregulation, reducing macrophage sensitivity and responsiveness to various pro-inflammatory and atherogenic stimuli and altering expression programs related to lipid uptake, storage, and inflammation. Additionally, the Bambi alleviated mitochondrial oxidative stress, further contributing to its protective effects. Notwithstanding the novel insights provided by this study, several inherent limitations warrant careful consideration and should inform future research directions. First, the translational applicability of findings derived from our animal model to human disease remains constrained. Although the high-fat diet-fed Apoe⁻/⁻ mouse represents a cornerstone model in atherosclerosis research and reliably develops hypercholesterolemia and lesions, substantial physiological and pathological differences from human atherosclerosis must be acknowledged. These include fundamental distinctions in lipoprotein profiles—mice are predominantly high-density lipoprotein cholesterol carriers—divergent inflammatory pathways, and differences in plaque morphology and stability. Murine plaques seldom progress to the vulnerable, rupture-prone phenotypes that precipitate acute cardiovascular events in humans. Consequently, the observed atheroprotective effects of Bambi must be interpreted cautiously. Validation in large animal models such as swine or non-human primates, which more accurately recapitulate human cardiovascular physiology and lesion complexity, or through studies utilizing human arterial tissues, will be essential to confirm clinical relevance. Second, the study’s focus on macrophages, though central to atherogenesis, overlooks the multicellular complexity of the atherosclerotic microenvironment. Disease pathogenesis involves intricate crosstalk among endothelial cells (ECs), VSMCs, and immune cells. Endothelial dysfunction is a critical initiating event, and VSMCs’ phenotypic switching contributes significantly to plaque growth and fibrous cap formation. The current investigation did not fully elucidate Bambi’s potential influence on ECs or VSMCs function, nor its role in modulating intercellular communication within plaques. The net atheroprotective effect observed may thus represent an integrated outcome of Bambi activity across multiple cell types, a hypothesis requiring further investigation using cell-specific experimental approaches. A third limitation arises from the lack of cell-type specificity in the adenovirus-mediated gene delivery system employed for in vivo overexpression. Although adenoviral vectors provide high transduction efficiency, their broad cellular tropism precludes exclusion of off-target effects in other cell types, such as hepatocytes or ECs, which may contribute to systemic alterations in lipid metabolism or inflammation and confound interpretation of macrophage-specific mechanisms. While in vitro evidence supports cell-autonomous effects in primary macrophages, future studies should utilize sophisticated genetic tools such as Cre-loxP systems with cell-specific promoters to unequivocally establish the macrophage-specific role of Bambi in vivo. Finally, although our data suggests a plausible mechanistic link between Bambi, Akt activation, and Tlr4 downregulation, this axis requires more rigorous validation to establish causality. Future studies should incorporate direct interventions, such as cell-type-specific genetic ablation or selective pharmacological inhibition of key signaling nodes, to definitively validate the proposed pathway. Moreover, from a translational standpoint, adenoviral vectors are unsuitable for therapeutic use due to immunogenicity and safety concerns. While this approach provides critical proof-of-concept, future efforts should prioritize the development of clinically tractable strategies, such as Bambi-targeting mimetics or CRISPR-based activation systems, to enable precise and safe therapeutic modulation. Interestingly, beyond the macrophage-specific effects, we also observed that Bambi overexpression appeared to attenuate high-fat diet-induced hepatic steatosis in Apoe−/− mice. This preliminary finding suggests potential systemic metabolic benefits of modulating Bambi expression, possibly through indirect mechanisms involving improved systemic lipid metabolism or inter-tissue communication. Given the established role of Apoe deficiency in promoting dyslipidemia and its systemic complications, including fatty liver disease, the alleviation of hepatic steatosis by Bambi overexpression hints at a broader therapeutic potential targeting metabolic syndrome components. However, the precise mechanistic link between Bambi overexpression and the amelioration of fatty liver remains unclear and warrants further investigation. Future studies are planned to specifically elucidate whether this effect is mediated through direct actions of Bambi in hepatocytes, or indirectly via alterations in systemic inflammation or lipid distribution, and to define the involved signaling pathways. Conclusion In summary, Bambi overexpression attenuates the progression of atherosclerosis through a multifaceted mechanism centered on the functional reprogramming of macrophages, which are pivotal mediators of inflammatory and lipid metabolism dysregulation in AS. The core pathway involves Bambi-mediated activation of the intracellular Akt signaling cascade, which in turn suppresses the expression of Tlr4, a key pattern recognition receptor that amplifies inflammatory responses and disrupts lipid homeostasis. This Akt-Tlr4 axis orchestrates a comprehensive amelioration of macrophage pathophysiology: it rectifies lipid metabolism by reducing excessive lipid uptake, enhancing cholesterol efflux, and promoting the hydrolysis of intracellular cholesteryl esters. Meanwhile, Bambi concurrently alleviates inflammatory status by curtailing overproduction of inflammatory cytokines and mitigating oxidative stress. Furthermore, Bambi also promotes a phenotypic shift in macrophage toward the atheroprotective M2 state. These concerted beneficial effects at the cellular level collectively impede the formation and development of atherosclerotic plaques, thereby reducing disease severity. Supplementary Information Supplementary Material 1 Acknowledgements We thank all the team members who participated in the study. Authors’ contributions All authors reviewed the manuscript. **X. C: ** Writing-review & editing, Writing-original draft, Investigation, Funding acquisition. **S. T: ** Writing-original draft, Investigation. **S. L: ** Writing-review & editing, Investigation. **P. S: ** Investigation, Funding acquisition. **H. G: ** Investigation, Funding acquisition. **A. X: ** Validation. **L. Z: ** Validation. **H. W: ** Funding acquisition. **Q. Y: ** Funding acquisition, Supervision, Project administration. Funding This work was supported by grants from the National Nature Science Foundation of China (grant number 82400996 and 82204543), Undergraduate Innovation and Entrepreneurship Training Program Funding Project of Xi’an Medical University (grant number 121524093 and 121525169), the Innovation Capability Support Program of Shaanxi (2025RS-CXTD-056), the Key Laboratory Project of the Shaanxi Provincial Department of Education (grant number 23JS053), and Natural Science Basic Research Program of Shaanxi Province (grant number 2024JC-YBQN-0227). Acknowledgments. Data availability The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Xiaochang Chen and Siyu Tan contributed equally to this work. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.